Please login to the form below

Gene testing

This page shows the latest Gene testing news and features for those working in and with pharma, biotech and healthcare.

Novartis partners with Bill & Melinda Gates Foundation on ‘accessible’ sickle cell gene therapy

Project will aim to discover and develop a gene therapy for sickle cell disease. ... Current gene therapies in clinical testing for SCD work by taking cells from a patient that are then altered in a laboratory and reintroduced to the patient in a process

Latest news

AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies

As part of this first deal, Voyager received $69m upfront to advance gene therapy candidates into phase 1 testing, with AbbVie gaining the option to license one or more for further ... In 2019, French drugmaker Sanofi also scaled back on a gene therapy
Astellas makes gene therapy a core focus with $3bn Audentes buy

Meanwhile, Audentes has several other candidates in development, including therapies for Pompe disease, Duchenne muscular dystrophy and myotonic dystrophy that are being prepared for clinical testing. ... It’s not the first gene therapy deal the
UniQure gets speedy US review for Huntington’s gene therapy

vector carrying gene designed to reduce levels of an overexpressed protein in Huntington’s disease. ... We are nearing the initiation of a phase 1/2 study of AMT-130, the first one-time administered AAV gene therapy to enter clinical testing for
Editas CEO exits the CRISPR firm ahead of first clinical trial

EDIT-101 is also expected to become the of Editas’ gene-editing medicines to start clinical testing, as the company recently got approval for an Investigational New Drug (IND) application for ... EDIT-101 is designed to be delivered directly into the
GSK: we won’t be splitting up any time soon

Also announced was a major new alliance with consumer gene testing company 23andMe.

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

Cell and gene therapy

And even for allogeneic cell therapies and gene therapies, raw materials and analytical testing costs will also need to be reduced” Davies said. ... As a result, Lonza’s efforts to reduce cell and gene therapy production costs involve logistics, said

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Senior Leadership Role – Medical Communications – North West: Highly Competitive Salary, Bonus &Benefits

Freelance Medical Writer - Creative Healthcare Comms - 2 month t...: Excellent Day Rate

Senior Account / Programme Manager - MedComms - Buckinghamshire: Highly Competitive Remuneration packages

Senior Content Editor - Biotechnology: Salary TBC

Account Management: Competitive Salary Offered

FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...: Highly Competitive Day Rate, Bonus &Benefits

Principal Medical Writer: Varies on experience

Freelance Account Manager - Creative Healthcare Comms - Immediat...: Excellent Day Rate

PMHub

Add my company

Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Virtual congresses: video thrilled the cardio tsar: Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?: The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.: Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....